Reboxetine Treatment in Depressed Children and Adolescents an 8-Week, Open Study
NCT00426946
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Depression
Interventions
DRUG:
Reboxetine
Sponsor
Geha Mental Health Center